Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.31 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.31 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5995314 | 0.95 | KDM4E (0.33) | L3MBTL1KDM4EHPGDLMNAMEN1 | |
| SCHEMBL5996661 | 0.93 | LMNA (0.34) | L3MBTL1KDM4EHPGDLMNAMEN1 | |
| SCHEMBL14641678 | 0.92 | KDM4E (0.37) | L3MBTL1KDM4EHPGDLMNAMEN1 | |
| SCHEMBL5995206 | 0.90 | L3MBTL1 (0.34) | L3MBTL1KDM4EMEN1KMT2A | |
| SCHEMBL1038153 | 0.90 | SMN1; SMN2 (0.34) | L3MBTL1KDM4EHPGDLMNAMEN1 | |
| SCHEMBL5995257 | 0.90 | TAS1R3 (0.34) | L3MBTL1KDM4ELMNASMN1; SMN2TAS1R3 | |
| SCHEMBL5997774 | 0.90 | HMGCR (0.32) | HPGD | |
| SCHEMBL5993788 | 0.89 | MEN1 (0.36) | L3MBTL1LMNAMEN1KMT2A | |
| SCHEMBL5997227 | 0.89 | LMNA (0.34) | L3MBTL1KDM4EHPGDLMNAMEN1 | |
| SCHEMBL5996443 | 0.88 | L3MBTL1 (0.36) | L3MBTL1KDM4EHPGDLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 359 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590177-B2 | Compound, curable resin composition, cured product, optical member, and lens | FUJIFILM CORPORATION (JP) | 2026-03-31 | — | — | US | disclosed |
| US-12570901-B2 | Cured product, curable resin composition, optical member, lens, diffractive optical element, multilayer diffractive optical element, and compound | FUJIFILM CORPORATION (JP) | 2026-03-10 | — | — | US | disclosed |
| WO-2026044148-A1 | LOW GLOSS ELECTRON BEAM CURABLE COATING COMPOSITIONS | PPG INDUSTRIES OHIO, INC. (US) | 2026-02-26 | — | — | WO | disclosed |
| US-12559616-B2 | Curable resin composition, cured product, diffractive optical element, and multilayer diffractive optical element | FUJIFILM CORPORATION (JP) | 2026-02-24 | — | — | US | disclosed |
| US-20250382406-A1 | CURABLE COMPOSITION, CURED PRODUCT, OPTICAL MATERIAL, DIFFRACTIVE OPTICAL ELEMENT, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2025-12-18 | — | — | US | disclosed |
| EP-4361224-B1 | METHOD FOR PRODUCING A PRINTED MATTER | TORAY INDUSTRIES (JP) | 2025-12-10 | — | — | EP | disclosed |
| EP-4660207-A1 | CURABLE COMPOSITION, CURED PRODUCT, OPTICAL MATERIAL, DIFFRACTIVE OPTICAL ELEMENT, AND COMPOUND | FUJIFILM Corporation (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-12434265-B2 | Coating method | TOKUYAMA CORPORATION (JP) | 2025-10-07 | — | — | US | disclosed |
| US-12428511-B2 | Resin composition, cured product, diffractive optical element, and multilayer diffractive optical element | FUJIFILM CORPORATION (JP) | 2025-09-30 | — | — | US | disclosed |
| US-20250277072-A1 | CURABLE COMPOSITION, CURED PRODUCT, OPTICAL MATERIAL, DIFFRACTIVE OPTICAL ELEMENT, AND MONOFUNCTIONAL (METH)ACRYLIC ACID THIOESTER MONOMER | FUJIFILM CORPORATION (JP) | 2025-09-04 | — | — | US | disclosed |
| US-6321014-B1 | Method for manufacturing optical fiber ribbon | ALCATEL (FR) | 2001-11-20 | — | — | US | disclosed |
| US-20010036978-A1 | Photoinitiator combinations | IGM GROUP B.V. (NL) | 2001-11-01 | — | — | US | disclosed |
| US-6251963-B1 | ORGAOPHOSPHOROUS COMPOUND CONTAINING KETONE GROUP | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-06-26 | — | — | US | disclosed |
| WO-2001002449-A2 | POLY(METH)ACRYLIC PHOTOCHROMIC COATING | PPG INDUSTRIES OHIO, INC. (US) | 2001-01-11 | — | — | WO | disclosed |
| EP-0773271-B1 | PROCESS FOR THE PRODUCTION OF PHOTOCHROMIC PRODUCT OF CURING | TOKUYAMA CORP (JP) | 1999-07-21 | — | — | EP | disclosed |
| US-5910516-A | PHOTOPOLYMERIZING AN UNSATURATED COMPOUND, AN ULTRAVIOLET PHOTOINITIATOR AND A PHOTOCHROMIC COMPOUND; USING A FILTER WHICH ELIMINATES THE UV LIGHT OF WAVELENGTH SHORTER THAN 400 NM. | TOKUYAMA CORPORATION (JP) | 1999-06-08 | — | — | US | disclosed |
| US-5880170-A | TRANSPARENT LENSES FORMED BY CURING | TOKUYAMA CORPORATION (JP) | 1999-03-09 | — | — | US | disclosed |
| EP-0795765-A2 | Photopolymerizable composition and transparent cured product thereof | TOKUYAMA CORPORATION (JP) | 1997-09-17 | — | — | EP | disclosed |
| EP-0773271-A1 | PROCESS FOR THE PRODUCTION OF PHOTOCHROMIC PRODUCT OF CURING | TOKUYAMA CORPORATION (JP) | 1997-05-14 | — | — | EP | disclosed |
| US-5534559-A | UNSATURATED POLYESTERS | CIBA-GEIGY CORPORATION (US) | 1996-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570901-B2 | Cured product, curable resin composition, optical member, lens, diffractive optical element, multilayer diffractive optical element, and compound | POLA1, POLR2A, POLR2B | L3MBTL1 2694/4885KDM4E 3292/4885HPGD 4272/4885 |
| US-20250382406-A1 | CURABLE COMPOSITION, CURED PRODUCT, OPTICAL MATERIAL, DIFFRACTIVE OPTICAL ELEMENT, AND COMPOUND | C5, Q6ZSR9, C9 | L3MBTL1 1941/4885KDM4E 1033/4885HPGD 3737/4885 |
| US-12559616-B2 | Curable resin composition, cured product, diffractive optical element, and multilayer diffractive optical element | CAD, TERB1, POT1 | L3MBTL1 3185/4885KDM4E 825/4885HPGD 4467/4885 |
| US-12590177-B2 | Compound, curable resin composition, cured product, optical member, and lens | RAD51, POLD1, POLR1A | L3MBTL1 1944/4885KDM4E 1435/4885HPGD 3210/4885 |
| US-12428511-B2 | Resin composition, cured product, diffractive optical element, and multilayer diffractive optical element | CAD, INTS9, NOP56 | L3MBTL1 4698/4885KDM4E 1575/4885HPGD 2827/4885 |
| US-20250277072-A1 | CURABLE COMPOSITION, CURED PRODUCT, OPTICAL MATERIAL, DIFFRACTIVE OPTICAL ELEMENT, AND MONOFUNCTIONAL (METH)ACRYLIC ACID THIOESTER MONOMER | CAD, ADCY1, AMD1 | L3MBTL1 990/4885KDM4E 1266/4885HPGD 1872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.